Valuation: Balchem Corporation

Market Cap 538.35Cr 467.99Cr 435.6Cr 399.93Cr 755.24Cr 51TCr 766.94Cr 5.13TCr 2.02TCr 26TCr 2.02TCr 1.98TCr 86TCr P/E 2026 *
32.2x
P/E 2027 * 31.2x
Enterprise Value 537.17Cr 466.96Cr 434.64Cr 399.05Cr 753.57Cr 51TCr 765.25Cr 5.12TCr 2.01TCr 26TCr 2.02TCr 1.97TCr 86TCr EV / Sales 2026 *
4.85x
EV / Sales 2027 * 4.48x
Free-Float
99.53%
Yield 2026 *
0.67%
Yield 2027 * 0.76%
1 day+2.97%
1 week+2.91%
1 month-0.83%
3 months+3.67%
6 months-1.54%
Current year+9.26%
1 week 160.46
Extreme 160.455
169.57
1 month 159.34
Extreme 159.34
170.34
Current year 152.58
Extreme 152.58
183.9
1 year 139.17
Extreme 139.17
183.9
3 years 110.74
Extreme 110.74
186.03
5 years 110.15
Extreme 110.1456
186.03
10 years 62.92
Extreme 62.92
186.03
Manager TitleAgeSince
Chief Executive Officer 61 28/04/2015
Director of Finance/CFO 49 04/02/2019
Chief Tech/Sci/R&D Officer 56 01/10/2025
Director TitleAgeSince
Director/Board Member 63 16/09/2010
Chairman 61 01/01/2017
Director/Board Member 59 15/09/2015
Date Insider Type Main position Quantity % Market Cap.
11/02/26 Free

Director

870 0.0027%
11/02/26 Free

Director

870 0.0027%
11/02/26 Free

General Counsel

11,315 0.0349%
Change 5-day change 1-year change 3-year change Capi.($)
+2.97%+2.91%+9.89%+24.35% 538.35Cr
-0.61%+3.30%+6.06%+51.59% 7.81TCr
-1.73%+1.06%-5.31%+9.90% 3.69TCr
+1.11%+16.68%-5.58%-32.82% 3.61TCr
-1.54%+4.03%+19.52%+37.21% 2.81TCr
-0.30%+3.61%+27.24%+12.60% 2.36TCr
-2.00%-2.43%+82.48%-9.00% 1.92TCr
-1.33%-0.51%-36.49%-41.17% 1.85TCr
-3.00%+2.53%+12.08%-10.34% 1.4TCr
-3.40%+0.09%+5.86%+64.60% 1.39TCr
Average -0.98%+3.13%+11.57%+10.69% 2.74TCr
Weighted average by Cap. -0.94%+3.99%+9.05%+16.45%

Financials

2026 *2027 *
Net sales 110.82Cr 96Cr 90Cr 82Cr 155.47Cr 11TCr 157.88Cr 1.06TCr 414.83Cr 5.27TCr 416.21Cr 407.06Cr 18TCr 116.69Cr 101.44Cr 94Cr 87Cr 163.7Cr 11TCr 166.23Cr 1.11TCr 436.79Cr 5.55TCr 438.23Cr 428.61Cr 19TCr
Net income 17Cr 15Cr 14Cr 12Cr 24Cr 1.61TCr 24Cr 160.43Cr 63Cr 799.38Cr 63Cr 62Cr 2.68TCr 17Cr 15Cr 14Cr 13Cr 24Cr 1.66TCr 25Cr 165.75Cr 65Cr 825.89Cr 65Cr 64Cr 2.77TCr
Net Debt -1.19Cr -1.03Cr -95.97L -88.12L -1.66Cr -113.23Cr -1.69Cr -11Cr -4.44Cr -56Cr -4.45Cr -4.36Cr -189.02Cr -15Cr -13Cr -12Cr -11Cr -22Cr -1.46TCr -22Cr -146.19Cr -57Cr -728.46Cr -58Cr -56Cr -2.44TCr
Logo Balchem Corporation
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Employees
1,352
Date Price Change Volume
31/26/31 $167.56 +2.97% 3,46,156
30/26/30 $162.73 -0.60% 2,71,851
29/26/29 $163.71 -1.25% 1,57,702
28/26/28 $165.79 +0.61% 3,17,890
27/26/27 $164.79 +1.22% 1,38,914
Trader
Investor
Global
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
167.56USD
Average target price
200.75USD
Spread / Average Target
+19.81%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BCPC Stock